KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 148 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,077 | -70.1% | 21,699 | -60.1% | 0.00% | -66.7% |
| Q2 2023 | $97,371 | -48.1% | 54,397 | +12.9% | 0.01% | -53.8% |
| Q1 2023 | $187,486 | +247.2% | 48,197 | +299.9% | 0.01% | +160.0% |
| Q2 2022 | $54,000 | -86.2% | 12,053 | -77.4% | 0.01% | -85.3% |
| Q1 2022 | $392,000 | +905.1% | 53,300 | +773.8% | 0.03% | +1033.3% |
| Q4 2021 | $39,000 | +3800.0% | 6,100 | +1880.5% | 0.00% | – |
| Q3 2021 | $1,000 | -96.6% | 308 | -84.9% | 0.00% | -100.0% |
| Q3 2020 | $29,000 | -86.6% | 2,039 | -82.0% | 0.00% | -85.7% |
| Q4 2019 | $216,000 | +200.0% | 11,300 | +167.0% | 0.02% | +320.0% |
| Q3 2018 | $72,000 | +3500.0% | 4,232 | +1497.0% | 0.01% | – |
| Q3 2015 | $2,000 | -96.1% | 265 | -75.9% | 0.00% | -100.0% |
| Q2 2014 | $51,000 | – | 1,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |